Farmacología

2014

1. Acute adverse reactions to iopromide vs iomeprol: A retrospective analysis of spontaneous reporting from a radiology department

   British Journal of Radiology, Vol. 87, Núm. 1033

2. Alcohol-related brain damage in humans

   PLoS ONE, Vol. 9, Núm. 4

3. Altered neuronal activity and differential sensitivity to acute antidepressants of locus coeruleus and dorsal raphe nucleus in Wistar Kyoto rats: A comparative study with Sprague Dawley and Wistar rats

   European Neuropsychopharmacology, Vol. 24, Núm. 7, pp. 1112-1122

4. Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats

   Neuropharmacology, Vol. 79, pp. 726-737

5. Combination antifungal therapy: A strategy for the management of invasive fungal infections

   Revista Espanola de Quimioterapia, Vol. 27, Núm. 3, pp. 141-158

6. Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results

   Drug Design, Development and Therapy, Vol. 8, pp. 263-277

7. Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain

   Journal of Neuroinflammation, Vol. 11, Núm. 1

8. Diferentes propiedades farmacológicas de ketanserina y altanserina sobre los receptores 5-HT2A en cerebro humano postmortem: Interés en estudio de esquizofrenia

   Actualidad en farmacología y terapéutica, Vol. 12, Núm. 1, pp. 59-63

9. Do post-mortem brain studies provide useful information for Psychiatry?

   Revista de Psiquiatria y Salud Mental, Vol. 7, Núm. 3, pp. 101-103

10. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment

    Neuropharmacology, Vol. 86, pp. 311-318

11. Evaluation of fentanyl disposition and effects in newborn piglets as an experimental model for human neonates

    PLoS ONE, Vol. 9, Núm. 3

12. FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: Basal contents and effects of psychotropic treatments

    Neuroscience, Vol. 277, pp. 541-551

13. Fast and efficient neural conversion of human hematopoietic cells

    Stem Cell Reports, Vol. 3, Núm. 6, pp. 1118-1131

14. Galanin activated Gi/o-proteins in human and rat central nervous systems

    Neuropeptides, Vol. 48, Núm. 5, pp. 295-304

15. Guanidine-based α2-adrenoceptor ligands: Towards selective antagonist activity

    European Journal of Medicinal Chemistry, Vol. 82, pp. 242-254

16. High-throughput analysis of lipid hydroperoxides in edible oils and fats using the fluorescent reagent diphenyl-1-pyrenylphosphine

    Food Chemistry, Vol. 162, pp. 235-241

17. Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease

    International Journal of Nanomedicine, Vol. 9, Núm. 1, pp. 2677-2687

18. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: Differential effect of antidepressant treatment

    Journal of Affective Disorders, Vol. 167, pp. 343-350

19. Interaction between the 5-HT system and the basal ganglia: Functional implication and therapeutic perspective in Parkinson's disease

    Frontiers in Neural Circuits, Vol. 8, Núm. MAR

20. Involvement of neuronal Nitric oxide synthase in desensitisation of μ-opioid receptors in the rat locus coeruleus

    Journal of Psychopharmacology, Vol. 28, Núm. 10, pp. 903-914